Six-lead device superior to single-lead smartwatch ECG in atrial fibrillation detection

Josca Scholten; Ward P. J. Jansen; Thomas Horsthuis; Anuska D. Mahes; Michiel M. Winter; Aeilko H. Zwinderman; Jan T. Keijer; Madelon Minneboo; Joris R. de Groot; Jouke P. Bokma

doi:https://doi.org/10.1016/j.ahj.2022.06.010

Six-lead device superior to single-lead smartwatch ECG in atrial fibrillation detection

Josca Scholten, Ward P. J. Jansen, Thomas Horsthuis, Anuska D. Mahes, Michiel M. Winter, Aeilko H. Zwinderman, Jan T. Keijer, Madelon Minneboo, Joris R. de Groot, Jouke P. Bokma

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Abstract

This was a head-to-head comparative study on different electrocardiogram (ECG)-based smartwatches and devices for atrial fibrillation detection. We prospectively included 220 patients scheduled for electrical cardioversion and recorded ECGs with 3 different devices (Withings Move ECG, Apple Watch 5, Kardia Mobile 6-leads) as well as the standard 12-lead ECG (gold standard), both before and after cardioversion. All atrial fibrillation detection algorithms had high accuracy (sensitivity and specificity: 91–99%) but were hampered by uninterpretable recordings (20–24%). In cardiologists’ interpretation, the 6-lead device was superior (sensitivity 99%, specificity 97%) to both single-lead smartwatches (P < .05) for atrial fibrillation detection.

Original language	English
Pages (from-to)	53-58
Number of pages	6
Journal	American heart journal
Volume	253
DOIs	https://doi.org/10.1016/j.ahj.2022.06.010
Publication status	Published - 1 Nov 2022

Access to Document

https://doi.org/10.1016/j.ahj.2022.06.010

Cite this

@article{4e83cd4f8e3d411188d1aec7d9fb0344,

title = "Six-lead device superior to single-lead smartwatch ECG in atrial fibrillation detection",

abstract = "This was a head-to-head comparative study on different electrocardiogram (ECG)-based smartwatches and devices for atrial fibrillation detection. We prospectively included 220 patients scheduled for electrical cardioversion and recorded ECGs with 3 different devices (Withings Move ECG, Apple Watch 5, Kardia Mobile 6-leads) as well as the standard 12-lead ECG (gold standard), both before and after cardioversion. All atrial fibrillation detection algorithms had high accuracy (sensitivity and specificity: 91–99%) but were hampered by uninterpretable recordings (20–24%). In cardiologists{\textquoteright} interpretation, the 6-lead device was superior (sensitivity 99%, specificity 97%) to both single-lead smartwatches (P < .05) for atrial fibrillation detection.",

author = "Josca Scholten and Jansen, {Ward P. J.} and Thomas Horsthuis and Mahes, {Anuska D.} and Winter, {Michiel M.} and Zwinderman, {Aeilko H.} and Keijer, {Jan T.} and Madelon Minneboo and {de Groot}, {Joris R.} and Bokma, {Jouke P.}",

note = "Funding Information: J.P. Bokma was supported by a research grant of Amsterdam Cardiovascular Sciences. All devices were purchased by the Cardiology department of Tergooi Hospital. Publisher Copyright: {\textcopyright} 2022 Elsevier Inc.",

year = "2022",

month = nov,

day = "1",

doi = "https://doi.org/10.1016/j.ahj.2022.06.010",

language = "English",

volume = "253",

pages = "53--58",

journal = "American Heart Journal",

issn = "0002-8703",

publisher = "Elsevier",

}

TY - JOUR

T1 - Six-lead device superior to single-lead smartwatch ECG in atrial fibrillation detection

AU - Scholten, Josca

AU - Jansen, Ward P. J.

AU - Horsthuis, Thomas

AU - Mahes, Anuska D.

AU - Winter, Michiel M.

AU - Zwinderman, Aeilko H.

AU - Keijer, Jan T.

AU - Minneboo, Madelon

AU - de Groot, Joris R.

AU - Bokma, Jouke P.

N1 - Funding Information: J.P. Bokma was supported by a research grant of Amsterdam Cardiovascular Sciences. All devices were purchased by the Cardiology department of Tergooi Hospital. Publisher Copyright: © 2022 Elsevier Inc.

PY - 2022/11/1

Y1 - 2022/11/1

N2 - This was a head-to-head comparative study on different electrocardiogram (ECG)-based smartwatches and devices for atrial fibrillation detection. We prospectively included 220 patients scheduled for electrical cardioversion and recorded ECGs with 3 different devices (Withings Move ECG, Apple Watch 5, Kardia Mobile 6-leads) as well as the standard 12-lead ECG (gold standard), both before and after cardioversion. All atrial fibrillation detection algorithms had high accuracy (sensitivity and specificity: 91–99%) but were hampered by uninterpretable recordings (20–24%). In cardiologists’ interpretation, the 6-lead device was superior (sensitivity 99%, specificity 97%) to both single-lead smartwatches (P < .05) for atrial fibrillation detection.

AB - This was a head-to-head comparative study on different electrocardiogram (ECG)-based smartwatches and devices for atrial fibrillation detection. We prospectively included 220 patients scheduled for electrical cardioversion and recorded ECGs with 3 different devices (Withings Move ECG, Apple Watch 5, Kardia Mobile 6-leads) as well as the standard 12-lead ECG (gold standard), both before and after cardioversion. All atrial fibrillation detection algorithms had high accuracy (sensitivity and specificity: 91–99%) but were hampered by uninterpretable recordings (20–24%). In cardiologists’ interpretation, the 6-lead device was superior (sensitivity 99%, specificity 97%) to both single-lead smartwatches (P < .05) for atrial fibrillation detection.

UR - http://www.scopus.com/inward/record.url?scp=85136541519&partnerID=8YFLogxK

U2 - https://doi.org/10.1016/j.ahj.2022.06.010

DO - https://doi.org/10.1016/j.ahj.2022.06.010

M3 - Comment/Letter to the editor

C2 - 35850242

VL - 253

SP - 53

EP - 58

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

ER -

Six-lead device superior to single-lead smartwatch ECG in atrial fibrillation detection

Abstract

Access to Document

Other files and links

Cite this